Micafungin use in a UK tertiary referral hospital
Conclusions We conclude that micafungin was clinically effective for the treatment of invasive candida and aspergillus infections and that usage did not increase the risk of liver dysfunction even in patients with abnormal ALT at baseline.
Source: Journal of Global Antimicrobial Resistance - Category: Infectious Diseases Source Type: research
More News: Abelcet | Antimicrobial Resistance | Aspergillosis | Aspergillus | Candida | Fluconazole | Fungal Infections | Infectious Diseases | Liver | Study | Teaching | Teaching Hospitals | Universities & Medical Training | Urology & Nephrology